share_log

T2 Biosystems | EFFECT: Others

T2 Biosystems | EFFECT: Others

T2 Biosystems | EFFECT:其他
美股SEC公告 ·  07/30 03:06

Moomoo AI 已提取核心訊息

T2 Biosystems, Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on July 29, 2024, at 4:00 P.M. The notice pertains to the Form S-3, which is typically used by companies to register securities for potential future offerings. The effectiveness of the form indicates that the SEC has reviewed and accepted the company's registration statement, allowing T2 Biosystems to proceed with the issuance of securities as outlined in the filing. The company's CIK number is 0001492674, and the file number associated with this notice is 333-280922.
T2 Biosystems, Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on July 29, 2024, at 4:00 P.M. The notice pertains to the Form S-3, which is typically used by companies to register securities for potential future offerings. The effectiveness of the form indicates that the SEC has reviewed and accepted the company's registration statement, allowing T2 Biosystems to proceed with the issuance of securities as outlined in the filing. The company's CIK number is 0001492674, and the file number associated with this notice is 333-280922.
T2 Biosystems公司是一家在美國上市的公司,於2024年7月29日下午4:00獲得了美國證券交易委員會(SEC)的有效公告。該公告涉及S-3表格,這通常是公司爲潛在的未來發行註冊證券所使用的表格。該表格的有效性表明SEC已經審查並接受了公司的註冊聲明,允許T2 Biosystems按照文件中概述的方式發行證券。該公司的CIK號碼爲0001492674,與此公告相關聯的文件編號爲333-280922。
T2 Biosystems公司是一家在美國上市的公司,於2024年7月29日下午4:00獲得了美國證券交易委員會(SEC)的有效公告。該公告涉及S-3表格,這通常是公司爲潛在的未來發行註冊證券所使用的表格。該表格的有效性表明SEC已經審查並接受了公司的註冊聲明,允許T2 Biosystems按照文件中概述的方式發行證券。該公司的CIK號碼爲0001492674,與此公告相關聯的文件編號爲333-280922。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息